MyFinsight
Home
Blog
About
Aktis Oncology, Inc. (AKTS)
Aktis Oncology, Inc. (AKTS)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
1632.65%
Quick Ratio
1632.65%
Cash Ratio
256.76%
Debt to Asset Ratio
13.05%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Operating lease right-of use ass...
Prepaid expenses and other curre...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Deferred revenue, net of current...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
Cash and cash equivalents
82,491
371,630
Marketable securities
434,829
166,854
Prepaid expenses and other current assets
7,219
5,456
Total current assets
524,539
543,940
Total property and equipment
23,042
21,492
Less accumulated depreciation and amortization
7,076
6,197
Property and equipment, net
15,966
15,295
Operating lease right-of use assets
12,230
12,816
Restricted cash equivalents
1,149
1,149
Other assets
3,712
3,601
Total assets
557,596
576,801
Accounts payable
2,533
1,227
Accrued expenses and other current liabilities
10,778
6,298
Deferred revenue, current portion
17,339
18,958
Operating lease liabilities, current portion
1,478
1,430
Total current liabilities
32,128
27,913
Deferred revenue, net of current portion
30,868
32,633
Operating lease liabilities, net of current portion
9,762
10,147
Total liabilities
72,758
70,693
Redeemable convertible preferred stock-Series Seed Redeemable Convertible Preferred Stock
0
0
Redeemable convertible preferred stock-Series ARedeemable Convertible Preferred Stock
0
0
Redeemable convertible preferred stock-Series A-1Redeemable Convertible Preferred Stock
0
0
Redeemable convertible preferred stock-Series BRedeemable Convertible Preferred Stock
0
0
Redeemable convertible preferred stock-Partner Redeemable Convertible Preferred Stock
0
0
Common stock value-Common Stock
5
5
Common stock value-Common Class A
0
0
Additional paid-in capital
684,611
681,233
Accumulated other comprehensive (loss) income
-745
-241
Accumulated deficit
-199,033
-174,889
Total stockholders' equity (deficit)
484,838
506,108
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)
557,596
576,801
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Marketable securities
$434,829K
Cash and cash
equivalents
$82,491K
Prepaid expenses and
other current assets
$7,219K
Total property and
equipment
$23,042K
Total current assets
$524,539K
Property and equipment,
net
$15,966K
Operating lease right-of
use assets
$12,230K
Other assets
$3,712K
Restricted cash
equivalents
$1,149K
Less accumulated
depreciation and...
$7,076K
Total assets
$557,596K
Total liabilities,
redeemable convertible...
$557,596K
Total stockholders'
equity (deficit)
$484,838K
Total liabilities
$72,758K
Accumulated deficit
-$199,033K
Accumulated other
comprehensive (loss) income
-$745K
Additional paid-in capital
$684,611K
Total current
liabilities
$32,128K
Deferred revenue, net of
current portion
$30,868K
Operating lease
liabilities, net of current...
$9,762K
Common stock
value-Common Stock
$5K
Deferred revenue,
current portion
$17,339K
Accrued expenses and
other current...
$10,778K
Accounts payable
$2,533K
Operating lease
liabilities, current portion
$1,478K
Buy us a coffee